University Of Health Sciences And
Pharmacy In St. Louis
CAGE Code: 7L734
NCAGE Code: 7L734
Status: Active
Type: Commercial Supplier
Dun & Bradstreet (DUNS): 075892844
Summary
University Of Health Sciences And, Pharmacy In St. Louis is an Active Commercial Supplier with the Cage Code 7L734 and is tracked by Dun & Bradstreet under DUNS Number 075892844..
Address
1 Pharmacy Pl
Saint Louis MO 63110
United States
Points of Contact
No Points of Contact...
Related Information
People who viewed this 'CAGE Code' also viewed...
Abdelmalek & Associates Inc. Pace Dh Dba Overhead Door Co Anheuser-Busch, Llc Imaging Resources Inc Alban Scientific, Inc. Loose Leaf Metals Co Mci Telecommunications Corp Koven Technology, Inc Robert N Covington Webb Kenneth W And Associates Environmental Management And N & J Railroad Contractors Inc. American Gateway Moving And Storage Braznell Co Noble Oak Creative Llc Brainz & Hustle Llc Mettler-Toledo Inc Gold Star Mobile Services & Six Sigma Unique Expression
Frequently Asked Questions (FAQ) for CAGE 7L734
- What is CAGE Code 7L734?
- 7L734 is the unique identifier used by NATO Organizations to reference the physical entity known as University Of Health Sciences And Pharmacy In St. Louis located at 1 Pharmacy Pl, Saint Louis MO 63110, United States.
- Who is CAGE Code 7L734?
- 7L734 refers to University Of Health Sciences And Pharmacy In St. Louis located at 1 Pharmacy Pl, Saint Louis MO 63110, United States.
- Where is CAGE Code 7L734 Located?
- CAGE Code 7L734 is located in Saint Louis, MO, USA.
Contracting History for CAGE 7L734 Most Recent 25 Records
- 75F40120C00150
- Eo14042 Incorporating Far 52.223-99, Ensuring Adequate Covid-19 Safety Protocols For Federal Contractors (Oct 2021) (Deviation).
- 5 Nov 2021
- Eo14042 Incorporating Far 52.223-99, Ensuring Adequate Covid-19 Safety Protocols For Federal Contractors (Oct 2021) (Deviation).
- Fda Office Of Acq Grant Svcs
- Department Of Health And Human Services (Hhs)
- $1,158,642.00
- Department Of Health And Human Services (Hhs)
- 75F40120C00150
- Fdabaa -20-00123 Robust In Vitro/In Silico Model To Accelerate Generic Drug Product Development For The Oral Cavity Route Of Administration
- 8 Mar 2023
- Fdabaa -20-00123 Robust In Vitro/In Silico Model To Accelerate Generic Drug Product Development For The Oral Cavity Route Of Administration
- Fda Office Of Acq Grant Svcs
- Department Of Health And Human Services (Hhs)
- $1,158,642.00
- Department Of Health And Human Services (Hhs)
- 75F40120C00150
- The Purpose Of This Modification Is To Allow For Approved / Requested Cost Share Level: 1.2 Person Months/Year For The Remaining 21 Months Of The Contract.
- 13 Dec 2023
- The Purpose Of This Modification Is To Allow For Approved / Requested Cost Share Level: 1.2 Person Months/Year For The Remaining 21 Months Of The Contract.
- Fda Office Of Acq Grant Svcs
- Department Of Health And Human Services (Hhs)
- $1,158,642.00
- Department Of Health And Human Services (Hhs)